01
20 years of theory
2005–2026: accumulated research on the genetic interrelations of human cells, small-intestinal symbiotic microbes and plant cells, from the intron's perspective.
03 / VPMI TECHNOLOGY
Living lactic acid bacteria that
turn plants into "bio-factories"
Vital Probiotics: plant lactic acid bacteria awakened by VPMI-CM. With activity above one billion CFU per gram, they mass-produce hundreds of starter strains and form low-molecular, high-density metabolite clusters that did not exist in the plant.
In plain words
Every plant hosts lactic acid bacteria that co-evolved with it (ELAB, endophytic lactic acid bacteria). In nature their power is weak. VPMI-CM is the plant-derived bio-catalyst that awakens them.
I call plant LAB activated by VPMI-CM Vital Probiotics. They produce miRNA and genetic material far more powerfully and abundantly than ELAB to form the metabolome. No bacteria are added from outside. The plant's own lactic acid bacteria metabolize the plant itself.
So VPMI turns a plant from a mere object of extraction into a "bio-factory" that produces starter strains.
≥ 10⁸ CFU/gactivity of Vital Probiotics (100× the ~10⁶ of ordinary kimchi)
1 billion CFU/gstrain production when plant–LAB reciprocity is high
hundredsvariety of strains produced in one process
100%technology rights held solely by the developer
Whoever holds VPMI-CM holds the starting point of the whole industry
The composition of VPMI-CM is a trade secret; reaching the same conclusion would take the same 20 years. And the one party that secures VPMI-CM exclusively can control the entire GRBM industry. This is the clearest barrier to entry we offer investors.
02
A black-box process
The composition of the core catalyst VPMI-CM is a trade secret; no similar technology has been disclosed in patents or papers.
03
A simple rights structure
All technology rights to GRBM and VPMI belong to the developer, making a transaction simple and fast.
Read moreCloseHigh-density metabolite clusters, the QL1–QL5 ladder, and links to the 9-Way lines
Ultra-high-density metabolite clusters — plant and LAB in mutualism
When the genetic reciprocity between a plant and its LAB is high, Vital Probiotics mass-produce hundreds of starter strains with activity above one billion CFU per gram. In the process, low-molecular, high-density metabolite clusters that never existed in the plant are formed, evolving into a key material that protects the body's metabolic rights.
QL1–QL5 — a quality ladder by purity and use
| Stage | Composition | Main market | Revenue profile |
|---|---|---|---|
| QL1 | Metabolized whole material | Premium food, concentrates, service ingredients | Fast cash flow |
| QL2 | Standardized metabolome ingredient | Food, beverage, B2B ingredients | Cash flow |
| QL3 | Purified fractions | Functional and beauty ingredients | High-margin B2B |
| QL4 | High-purity applied materials | Medical nutrition, high-function ingredients | High-margin B2B |
| QL5 | Drug-candidate research materials | Precision drug candidates (MHM-PI) | Rising enterprise value |
QL1–QL2 drive cash flow, QL3–QL4 high-margin B2B ingredients, and QL5 the rise in enterprise value. QL is the company's internal quality classification; specifications at each stage are confirmed by product test reports.
The three-step definition of the technology
-
01
Step 1
Low-salt lactic acid bacteria kimchi technology
-
02
Step 2
Salt-free bio-metabolized kimchi by plant LAB, and Metabolomed Protein technology
-
03
Step 3
Green Red BIO Metabolome technology
External miRNA is a basic element appearing in every step, not tied to one specific step. See the three-step evolution for the records of each step.
Source: the developer's (Wooyoung Nam's) research and company process data. Figures such as viable counts and amino acid composition are confirmed by product- and batch-specific test reports.
PARTNERSHIP · INVESTMENT
The world's first true eco-bio platform technology —
we are looking for the one partner
After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.